ロード中...
CD40L inhibits cell growth of THP-1 cells by suppressing the PI3K/Akt pathway
INTRODUCTION: Acute myeloid leukemia (AML), the hematological malignant tumor with high mortality, is still difficult to treat. CD40L is a type II transmembrane protein, which has been reported to have the potential to inhibit growth of some cancer cells. MATERIALS AND METHODS: In order to determine...
保存先:
| 出版年: | Onco Targets Ther |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Dove Medical Press
2019
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6476227/ https://ncbi.nlm.nih.gov/pubmed/31114244 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S175347 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|